GENB
Financials
- Market Capitalization 1.97 B
- Employee 312
- Founded 2018
- CEO N/A
- Website www.generatebiomedicines.com
- Headquarter Delaware, United States
- FIGI BBG00X9D0NZ0
- Industry Drug Manufacturers—General
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1896 |  RAPP Rapport Therapeutics, Inc. - Common Stock | 48.77 USD | -4.05% | +1.27% | +16.98% | +86.22% | 2.34 B USD | ||
| 1954 |  PVLA Palvella Therapeutics, Inc. - Common Stock | 149.97 USD | -0.24% | +7.11% | +3.79% | +103.07% | 2.16 B USD | ||
| 2181 |  MAZE Maze Therapeutics, Inc. - Common Stock | 27.44 USD | -4.06% | -6.25% | -0.11% | -39.06% | 1.52 B USD | ||
| 2742 |  CBIO Crescent Biopharma, Inc. - Common Stock | 17.75 USD | -0.06% | +3.50% | +21.08% | +22.50% | 659.30 M USD |
Frequently asked questions about Generate Biomedicines, Inc. Common Stock
What is the Generate Biomedicines, Inc. Common Stock stock price today?
The current price of Generate Biomedicines, Inc. Common Stock (GENB) is 15.33. Over the past 24 hours, the stock has changed by -2.79%. Follow the GENB chart for real-time price dynamics.
What is the stock ticker of Generate Biomedicines, Inc. Common Stock?
Generate Biomedicines, Inc. Common Stock trades under the ticker GENB. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Generate Biomedicines, Inc. Common Stock stock going up?
GENB has changed by -8.53% over the last week, +16.93% over the last month, and +2.20% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Generate Biomedicines, Inc. Common Stock?
Generate Biomedicines, Inc. Common Stock currently has a market capitalization of 1.97 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Generate Biomedicines, Inc. Common Stock earnings last quarter?
Last quarter, Generate Biomedicines, Inc. Common Stock reported earnings of -0.52 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Generate Biomedicines, Inc. Common Stock revenue for the last quarter?
Generate Biomedicines, Inc. Common Stock reported quarterly revenue of 6.31 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Generate Biomedicines, Inc. Common Stock net income for the last quarter?
Generate Biomedicines, Inc. Common Stock reported net income of -67.25 M for the last quarter. The previous quarter showed -61.45 M, which means net income changed by -9.45%.
How many employees does Generate Biomedicines, Inc. Common Stock have?
As of the latest available data, Generate Biomedicines, Inc. Common Stock has 312 employees. Workforce size can provide additional context about the company's scale and operations.
What is Generate Biomedicines, Inc. Common Stock EBITDA?
Generate Biomedicines, Inc. Common Stock EBITDA is -68.39 M, and its EBITDA margin is -1 083.15%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Generate Biomedicines, Inc. Common Stock stock?
You can buy Generate Biomedicines, Inc. Common Stock (GENB) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Generate Biomedicines, Inc. Common Stock stock?
Investing in Generate Biomedicines, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the GENB chart and related analysis on metatrader.com as part of your research.